Bafna Pharmaceuticals Ltd

BAFNAPH Stock View

(NSE)

99.05

234.67
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Bafna Pharmaceuticals Ltd stands at 5 against 5, three months back.

Bafna Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in the manufacture of drugs and medicines. The Company is manufacturing over 336 licensed pharmaceutical formulations and has globally registered approximately 78 of its products. The Company caters to both domestic and international markets. The Company has two manufacturing facilities in Chennai. Its Madhavram facility manufactures finished solid oral and liquid oral dosage forms of Betalactam and Non-Betalactam and Cephalosporin products. The Company supplies its finished products to countries including Sri Lanka, Ghana, Ukraine, and Laos. The Company's subsidary include Bafna Lifestyles Remedies Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
101.44
100 DMA ()
106.60
200 DMA ()
117.63
52 Weeks Range
95.05
185.50
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp